Office of Research & Development |
![]() ![]() |
Project Number: | I01BX002829-05 |
Title: | Immunomodulation and Neuroprotection in Multiple Sclerosis |
Principal Investigator: | Inderjit Singh |
Location: | Charleston, SC |
Congressional District Code: | 1 |
Research Service: | Biomedical Laboratory R&D |
Project Period: | April 2019 - March 2023 |
FY 2021 Funding Amount: | $254,646 |
Total Award Amount (all years): |
$1,075,228 |
Abstract: |
View full abstract and other project information on NIH RePORTER Go To NIH RePORTER Excerpt: Multiple sclerosis (MS), a disabling autoimmune disease affecting almost 2.5 million people around the world, affects individuals in their most productive years and is prevalent among US Veterans. MS is caused by abnormal activation of myelin-specific autoreactive lymphocytes and their CNS infiltration across the blood- brain barrier (BBB). Present day FDA approved MS drugs, targeting immune system, have limited efficacies as disease progression continues. In an effort to improve MS therapy, the... |